www.leukine.com: Patients and Caregivers

Leukine® (sargramostim) is contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (≥ 10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any components of Leukine, and for concomitant use with chemotherapy and radiotherapy. Please see Full Prescribing Information.

www.wafdo.org: WAFDO Website

The Western Association of Food and Drug Officials is organized for the purpose of improving communication and cooperation with the respective local, state, and federal programs, and for promoting the development and enforcement of uniform food, drug, and consumer protection laws.